Position in VTRS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$42,481,369
-$25,095,549 QoQ
Shares Held
3,144,439
-42.1% QoQ
Ownership
0.270%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Derivatives in VTRS
reported options exposure · as of Sep 30, 2024CallValue
$0
CallShares
0
PutValue
$1,161
PutShares
100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $516,666,064 across 52 Drug Manufacturers - Specialty & Generic names. VTRS ranks #3 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,809,925 | $213,951,231 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,745,751 | $53,210,488 | |
| 3 | VTRS |
Viatris Inc
This page
|
3,144,439 | $42,481,369 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,400,671 | $42,188,210 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
63,005 | $37,360,703 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
243,984 | $32,142,450 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
971,854 | $13,508,770 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
639,372 | $13,273,362 |
All Filings in VTRS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $42,481,369 | 3,144,439 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $67,576,918 | 5,427,865 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $53,219,963 | 5,375,754 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $49,396,686 | 5,531,544 | Shares | Defined | 2026-02-27 | |
| 2025-03-31 | $29,332,743 | 3,367,709 | Shares | Defined | 2026-03-17 | |
| 2024-12-31 | $36,970,010 | 2,969,479 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $1,161 | 100 | Put | Sole | 2026-03-31 | |
| 2024-09-30 | $29,947,934 | 2,579,495 | Shares | Defined | 2026-03-31 | |
| 2024-06-30 | $28,944,339 | 2,722,892 | Shares | Defined | 2026-03-23 | |
| 2024-03-31 | $39,012,801 | 3,267,404 | Shares | Defined | 2026-03-24 | |
| 2023-12-31 | $33,611,032 | 3,103,512 | Shares | Defined | 2026-03-24 | |
| 2023-12-31 | $3,249,000 | 300,000 | Call | Sole | 2026-03-24 | |
| 2023-09-30 | $5,916,000 | 600,000 | Call | Sole | 2026-03-26 | |
| 2023-09-30 | $22,382,868 | 2,270,068 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $24,626,275 | 2,467,563 | Shares | Defined | 2026-03-27 | |
| 2023-03-31 | $962,000 | 100,000 | Call | Sole | 2026-03-30 | |
| 2023-03-31 | $13,923,226 | 1,447,321 | Shares | Defined | 2026-03-30 | |
| 2022-12-31 | $22,439,135 | 2,016,095 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $23,380,198 | 2,744,155 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $23,663,455 | 2,260,120 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $34,563,245 | 3,176,769 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||